NeuroSov - Ana Clara Cristóvão
NeuroSoV was recently founded by Ana Clara Cristóvão, PhD in Cell Biology by the University of Coimbra (Portugal) and key investigator in several research projects funded by FCT, NIH and Michael J. Fox Foundation. NeuroSoV is an implemented technology transfer startup launched by UBImedical incubation program (University of Beira Interior, Covilhã, Portugal). It offers pre-clinical validation services to academic/pharmaceutical companies aiming to validate small molecules with therapeutic potential for Parkinson’s disease. Nevertheless, it aims to increase its potential business to other neurological disorders, like Alzheimer's disease and stroke. Neurosov is in the process of submitting the first patent for a small molecule, and it will be soon involved in the trademark registry as well. The company already has several international clients in the area of the pharmaceutical industry. Currently, NeuroSov seeks investors to support the initial stages of business creation, marketing and an introduction of the business concept both nationally and internationally.